New warnings for Tarceva cancer drug-U.S. FDA

New warnings have been added to Genentech Inc and OSI Pharmaceutical Inc's (OSIP.O) cancer drug Tarceva about serious complications such as skin reactions and holes in the digestive tract, U.S. health regulators said on Friday.

In some cases patients have died, the U.S. Food and Drug Administration said.

The FDA said that some of the problems suggest larger possible disorders such as Stevens-Johnson syndrome or toxic epidermal necrolysis.

Genentech is a unit of Roche Holding AG (ROG.VX). (Reporting by Susan Heavey).

Source : uk.reuters.com